Psyence Biomedical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PBM and other ETFs, options, and stocks.About PBM
Psyence Biomedical Ltd. is a holding company, which engages in the development and commercialization of pharmaceutical products in neurology. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care.
CEOJody Aufrichtig
CEOJody Aufrichtig
Employees12
Employees12
HeadquartersToronto, Ontario
HeadquartersToronto, Ontario
Founded2021
Founded2021
Employees12
Employees12
PBM Key Statistics
Market cap1.65M
Market cap1.65M
Price-Earnings ratio0.52
Price-Earnings ratio0.52
Dividend yield—
Dividend yield—
Average volume3.86M
Average volume3.86M
High today$0.9097
High today$0.9097
Low today$0.8057
Low today$0.8057
Open price$0.90
Open price$0.90
Volume241.27K
Volume241.27K
52 Week high$18.44
52 Week high$18.44
52 Week low$0.80
52 Week low$0.80
Stock Snapshot
Psyence Biomedical(PBM) stock is priced at $0.81, giving the company a market capitalization of 1.65M. It carries a P/E multiple of 0.52.
As of 2025-12-30, Psyence Biomedical(PBM) stock has fluctuated between $0.81 and $0.91. The current price stands at $0.81, placing the stock 0.0% above today's low and -11.4% off the high.
Psyence Biomedical(PBM) shares are trading with a volume of 241.27K, against a daily average of 3.86M.
During the past year, Psyence Biomedical(PBM) stock moved between $0.80 at its lowest and $18.44 at its peak.
During the past year, Psyence Biomedical(PBM) stock moved between $0.80 at its lowest and $18.44 at its peak.
People also own
Based on the portfolios of people who own PBM. This list is generated using Robinhood data, and it’s not a recommendation.